Lumida
/NKTX
⌘K
Nkarta Inc

Nkarta Inc

NKTX
$2.91USD+3.56%+0.10 today

MARKET CAP

208.4M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$2
$4

AI Summary

Stalk
Buy NowMedium

NKTX exhibits a clear sequence of higher highs and higher lows within a Stage 2 advance, with price accepting pullbacks into rising EMAs and reclaiming support. The medium-term structure remains bullish, reinforced by our Speculative strategy’s preference for continuation setups. Short-term timing is favorable as price tracks above the 9/20 EMAs and rebounds from recent consolidation. We recommend engaging now on a pullback interaction around the EMA zone, targeting continuation of the established uptrend.

  • Holds $243.2M in cash, supporting R&D through 2029
  • Enrolling patients in NKX019 Ntrust-1/2 trials with expected early data
  • Q2 2026 net loss of $40.4M ($0.54/sh) highlights steep losses
Full analysis →
Insider Trades23 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 18, 2026SellNKTXPaul J HastingsChief Executive Officer1,776$2.71$208.4M-21.77%+71.18%$4.8K-0.45%Buy Now
Jan 15, 2026SellNKTXNadir MahmoodPresident5,649$2.07$208.4M-21.77%+71.18%$11.7K-3.26%Buy Now
Jan 15, 2026SellNKTXPaul J HastingsChief Executive Officer26,046$2.07$208.4M-21.77%+71.18%$53.9K-6.26%Buy Now
Jun 18, 2025SellNKTXPaul J HastingsChief Executive Officer1,790$1.79$208.4M-21.77%+71.18%$3.2K-0.56%Buy Now
Jan 15, 2025SellNKTXAlyssa Levin5,838$2.20$208.4M-21.77%+71.18%$12.8K-5.38%Buy Now
Jan 15, 2025SellNKTXRalph BrandenbergerChief Technical Officer7,447$2.20$208.4M-21.77%+71.18%$16.4K-5.63%Buy Now
Jan 15, 2025SellNKTXDavid Shook8,638$2.20$208.4M-21.77%+71.18%$19.0K-4.33%Buy Now
Jan 15, 2025SellNKTXAlicia J. HagerChief Legal Officer9,584$2.20$208.4M-21.77%+71.18%$21.1K-6.13%Buy Now
Jan 15, 2025SellNKTXPaul J HastingsChief Executive Officer17,378$2.20$208.4M-21.77%+71.18%$38.2K-5.15%Buy Now
Aug 21, 2024BuyNKTXDavid Shook1,352$5.11$208.4M-21.77%+71.18%$6.9K+0.99%Buy Now
Jul 16, 2024SellNKTXAlicia J. HagerChief Legal Officer3,396$8.00$208.4M-21.77%+71.18%$27.2K-3.17%10b5-1Buy Now
Jun 18, 2024SellNKTXRalph BrandenbergerChief Technical Officer229$5.60$208.4M-21.77%+71.18%$1.3K-0.29%Buy Now
Jun 18, 2024SellNKTXDavid ShookChief Medical Officer456$5.60$208.4M-21.77%+71.18%$2.6K-0.39%Buy Now
Jun 18, 2024SellNKTXJames TragerChief Scientific Officer456$5.60$208.4M-21.77%+71.18%$2.6K-0.30%Buy Now
Jun 18, 2024SellNKTXAlicia J. HagerChief Legal Officer727$5.60$208.4M-21.77%+71.18%$4.1K-0.67%Buy Now
Jun 18, 2024SellNKTXPaul J HastingsChief Executive Officer1,770$5.60$208.4M-21.77%+71.18%$9.9K-0.73%Buy Now
Mar 1, 2024SellNKTXRalph BrandenbergerChief Technical Officer15,130$8.66$208.4M-21.77%+71.18%$131.0K-0.53%10b5-1Buy Now
Feb 12, 2024SellNKTXJames TragerChief Scientific Officer4,143$12.00$208.4M-21.77%+71.18%$49.7K-2.70%10b5-1Buy Now
Jan 16, 2024SellNKTXRalph BrandenbergerChief Technical Officer2,512$8.74$208.4M-21.77%+71.18%$22.0K-2.99%Buy Now
Jan 16, 2024SellNKTXDavid ShookChief Medical Officer3,552$8.74$208.4M-21.77%+71.18%$31.0K-3.00%Buy Now
Jan 16, 2024SellNKTXAlicia J. HagerChief Legal Officer4,554$8.74$208.4M-21.77%+71.18%$39.8K-4.05%Buy Now
Jan 16, 2024SellNKTXJames TragerChief Scientific Officer4,560$8.74$208.4M-21.77%+71.18%$39.9K-2.88%Buy Now
Jan 16, 2024SellNKTXPaul J HastingsChief Executive Officer9,697$8.74$208.4M-21.77%+71.18%$84.8K-2.42%Buy Now